Yao-Hua Song

Dr. Yao-Hua Song


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2023 in Signal Transduction and Targeted Therapy
Verified
Journal Article
Open access
PDF file
LJLijuan Jiao
Lijuan Jiao
YLYuzhe Liu
Yuzhe Liu
XYXi-Yong Yu
Xi-Yong Yu
XPXiangbin Pan
Xiangbin Pan
YZYu Zhang
Yu Zhang
YLYangxin Li
Yangxin Li
The ribosome is a multi-unit complex that translates mRNA into protein. Ribosome biogenesis is the process that generates ribosomes and plays an essential role in cell proliferation, differentiation, apoptosis, development, and transformation. The mTORC1, Myc, and noncoding RNA signaling pathways are the primary mediators that work jointly with RNA polymerases and ribosome proteins to control ribosome biogenesis and protein synthesis. Activation of mTORC1 is required for normal fetal growth and development and tissue regeneration after birth. Myc is implicated in cancer development by enhancing RNA Pol II activity, leading to uncontrolled cancer cell growth. The deregulation of noncoding RNAs such as microRNAs, long noncoding RNAs, and circular RNAs is involved in developing blood, neurodegenerative diseases, and atherosclerosis. We review the similarities and differences between eukaryotic and bacterial ribosomes and the molecular mechanism of ribosome-targeting antibiotics and bacterial resistance. We also review the most recent findings of ribosome dysfunction in COVID-19 and other conditions and discuss the consequences of ribosome frameshifting, ribosome-stalling, and ribosome-collision. We summarize the role of ribosome biogenesis in the development of various diseases. Furthermore, we review the current clinical trials, prospective vaccines for COVID-19, and therapies targeting ribosome biogenesis in cancer, cardiovascular disease, aging, and neurodegenerative disease.

2 July 2021 in Signal Transduction and Targeted Therapy
Verified
Journal Article
Open access
PDF file
YLYangxin Li
Yangxin Li
HHHui Huang
Hui Huang
BLBin Liu
Bin Liu
YZYu Zhang
Yu Zhang
XPXiangbin Pan
Xiangbin Pan
YSYao-Hua Song
Yao-Hua Song
Inflammasomes are protein complexes of the innate immune system that initiate inflammation in response to either exogenous pathogens or endogenous danger signals. Inflammasome multiprotein complexes are composed of three parts: a sensor protein, an adaptor, and pro-caspase-1. Activation of the inflammasome leads to the activation of caspase-1, which cleaves pro-inflammatory cytokines such as IL-1β and IL-18, leading to pyroptosis. Effectors of the inflammasome not only provide protection against infectious pathogens, but also mediate control over sterile insults. Aberrant inflammasome signaling has been implicated in the development of cardiovascular and metabolic diseases, cancer, and neurodegenerative disorders. Here, we review the role of the inflammasome as a double-edged sword in various diseases, and the outcomes can be either good or bad depending on the disease, as well as the genetic background. We highlight inflammasome memory and the two-shot activation process. We also propose the M- and N-type inflammation model, and discuss how the inflammasome pathway may be targeted for the development of novel therapy.

1 May 2016 in Trends in Endocrinology & Metabolism
Verified
Journal Article
Closed access
JZJin Zhou
Jin Zhou
BLBin Liu
Bin Liu
CLChun Liang
Chun Liang
YLYangxin Li
Yangxin Li
YSYao-Hua Song
Yao-Hua Song

1 June 2013 in Trends in Endocrinology & Metabolism
Verified
Journal Article
Closed access
YSYao-Hua Song
Yao-Hua Song
JSJenny L. Song
Jenny L. Song
PDPatrice Delafontaine
Patrice Delafontaine
MGMichael P. Godard
Michael P. Godard

18 November 2024 in Signal Transduction and Targeted Therapy
Verified
Journal Article
Open access
PDF file
YLYangxin Li
Yangxin Li
YLYuzhe Liu
Yuzhe Liu
XYXi-Yong Yu
Xi-Yong Yu
YXYan Xu
Yan Xu
XPXiangbin Pan
Xiangbin Pan
ZSZhenya Shen
Zhenya Shen
Once considered unconventional cellular structures, membraneless organelles (MLOs), cellular substructures involved in biological processes or pathways under physiological conditions, have emerged as central players in cellular dynamics and function. MLOs can be formed through liquid-liquid phase separation (LLPS), resulting in the creation of condensates. From neurodegenerative disorders, cardiovascular diseases, aging, and metabolism to cancer, the influence of MLOs on human health and disease extends widely. This review discusses the underlying mechanisms of LLPS, the biophysical properties that drive MLO formation, and their implications for cellular function. We highlight recent advances in understanding how the physicochemical environment, molecular interactions, and post-translational modifications regulate LLPS and MLO dynamics. This review offers an overview of the discovery and current understanding of MLOs and biomolecular condensate in physiological conditions and diseases. This article aims to deliver the latest insights on MLOs and LLPS by analyzing current research, highlighting their critical role in cellular organization. The discussion also covers the role of membrane-associated condensates in cell signaling, including those involving T-cell receptors, stress granules linked to lysosomes, and biomolecular condensates within the Golgi apparatus. Additionally, the potential of targeting LLPS in clinical settings is explored, highlighting promising avenues for future research and therapeutic interventions.

1 March 2015 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
QZQ. Zhao
Q. Zhao
SYS.T. Yang
S.T. Yang
JWJ.J. Wang
J.J. Wang
JZJ. Zhou
J. Zhou
SXS.S. Xing
S.S. Xing
YSYao-Hua Song
Yao-Hua Song